
The results are presented of palliative telecobaltotherapy in patients with metastases to the brain. The patients received a dose of 30 Gy in 10 fractions during 2 weeks. Clinical improvement was achieved in 28 out of 33 treated patients (85%). The survival time after the completion of radiotherapy was from 1 to 15 months, mean 5 months.
Adult, Male, Lung Neoplasms, Brain Neoplasms, Common Bile Duct Neoplasms, Breast Neoplasms, Middle Aged, Humans, Female, Cobalt Radioisotopes, Radioisotope Teletherapy, Aged
Adult, Male, Lung Neoplasms, Brain Neoplasms, Common Bile Duct Neoplasms, Breast Neoplasms, Middle Aged, Humans, Female, Cobalt Radioisotopes, Radioisotope Teletherapy, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
